Vitrolife AB (publ) (OTCMKTS:VTRLY – Get Free Report) was the recipient of a significant increase in short interest in June. As of June 30th, there was short interest totaling 170 shares, an increase of ∞ from the June 15th total of 0 shares. Based on an average daily volume of 60 shares, the short-interest ratio is presently 2.8 days.
Vitrolife AB (publ) Price Performance
OTCMKTS:VTRLY opened at $9.50 on Friday. Vitrolife AB has a 12 month low of $9.50 and a 12 month high of $18.55. The business’s fifty day moving average price is $10.69 and its 200 day moving average price is $11.59.
About Vitrolife AB (publ)
Vitrolife AB (publ) is a Sweden‐based life science company specializing in products and systems for in vitro fertilization (IVF) and assisted reproductive technologies. Founded in 1994 and headquartered in Gothenburg, the company develops, manufactures and markets a comprehensive portfolio of consumables, culture media and instruments that support the entire IVF process, from gamete handling to embryo culture and cryopreservation.
The company’s product range includes embryo culture media, blastocyst media, vitrification solutions and pipetting tools designed to optimize laboratory workflows and improve outcomes for fertility clinics and patients.
Featured Stories
- Five stocks we like better than Vitrolife AB (publ)
- Why Abbott Laboratories Stock Is Suddenly Winning Back Wall Street
- Revving Up Returns: Big Banks Race Through the Rate Plateau
- Why Uber’s Biggest Deal Yet Could Unlock Its Next Growth Phase
- Why Microsoft Is Playing a Different AI Game Than Big Tech—and Cash Flow Is the Test
Receive News & Ratings for Vitrolife AB (publ) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vitrolife AB (publ) and related companies with MarketBeat.com's FREE daily email newsletter.
